| ID | Sequence | Length | GC content |
|---|---|---|---|
| lnc-C1orf61-2:40 | AAGACUGUGAUGGCCAAAUGAAACCCACUGGAUUUUAAGAUAAGGAGAU… | 520 nt | 0.4327 |
| lnc-C1orf61-2:5 | CAGCGCCCUCUGUCCUCCUGGCCGUUUUCCUGAACUCCUAACCUCAGUC… | 446 nt | 0.5314 |
| lnc-C1orf61-2:6 | CGUUUUCCUGAACUCCUAACCUCAGUCAAUACUGCCUCGGGACCUGGCG… | 675 nt | 0.4459 |
| lnc-C1orf61-2:7 | GAAGAAAGGAAGCAUCUUGGCCCCUGCCUUGGGGGCGACACGACCGUCC… | 382 nt | 0.5314 |
| lnc-C1orf61-2:8 | UCCCCAAACACAGCGAGUCACUGGCCUGGGUCUUUGUGCAGAGGCCCCU… | 523 nt | 0.4512 |
| lnc-C1orf61-2:9 | GGACCCGGUCUAUAGACUCUGACCUUAGCCCUCAGAAUCCCUCAUUCAG… | 1575 nt | 0.4965 |
No relevant information is available at the moment.
A study in humans demonstrated that the mRNA biomarker C1orf61, when analyzed via RT-qPCR, successfully differentiated brain tissue/blood mixtures from pure blood in autopsy samples [Lux et al. DOI:10.1016/j.forsciint.2014.01.016].